Senior insider sale
Chief Executive Officer at QUINCE THERAPEUTICS, INC. — senior position signals high conviction
$133.3K
3.70K shares
What this filing means
THYE DIRK plans to sell 3.70K shares of QUINCE THERAPEUTICS, INC. valued at approximately $133.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/21/2026ACC: 0001628280-26-066751
DirectorOfficer· Chief Executive Officer
Since May 2022
3.70K
Shares to sell
$133.3K
Approx. market value
3.70K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU
CASH
10/30/2025
3.70KTotal acquired3.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/30/2025 | RSU CASH | 3.70K | — |
| Total | 3.70K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.70K
Market value
$133.3K
10/21/2026
Total
Units
3.70K
Value
$133.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/21/2026 | 3.70K | $133.3K | NASDAQ | Planned |
| Total | 3.70K | $133.3K | ||